Search research articles
Contact Us
Filters
Showing results (221-230 of 330) with videos related to
Page
of 33
Sort By:
Breast Cancer Research : BCR
|
December 1, 2020
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
Jose Pablo Leone, Kyrre E Emblem, Michelle Weitz, et al.
Nature Communications
|
October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence
Yu Gu, Tarek Taifour, Tung Bui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
NPJ Breast Cancer
|
February 13, 2026
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer
Paolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, et al.
Breast Cancer Research : BCR
|
February 20, 2020
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
Christos Vaklavas, Brian S Roberts, Katherine E Varley, et al.
Cancer
|
December 15, 2020
Perceptions of patients with early stage breast cancer toward research biopsies
Davinia S Seah, Jose Pablo Leone, Thomas H Openshaw, et al.
Nature Communications
|
March 20, 2024
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
Sheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
NPJ Breast Cancer
|
February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)
Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
Journal of Neuro-Oncology
|
July 26, 2014
Local control after fractionated stereotactic radiation therapy for brain metastases
Selvan Rajakesari, Nils D Arvold, Rachel B Jimenez, et al.
Page
of 33
Search research articles
Search
Showing results (221-230 of 330) with videos related to
Sort By:
Page
of 33
Breast Cancer Research : BCR
|
December 1, 2020
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
Jose Pablo Leone, Kyrre E Emblem, Michelle Weitz, et al.
Nature Communications
|
October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence
Yu Gu, Tarek Taifour, Tung Bui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
NPJ Breast Cancer
|
February 13, 2026
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer
Paolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, et al.
Breast Cancer Research : BCR
|
February 20, 2020
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
Christos Vaklavas, Brian S Roberts, Katherine E Varley, et al.
Cancer
|
December 15, 2020
Perceptions of patients with early stage breast cancer toward research biopsies
Davinia S Seah, Jose Pablo Leone, Thomas H Openshaw, et al.
Nature Communications
|
March 20, 2024
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
Sheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
NPJ Breast Cancer
|
February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)
Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
Journal of Neuro-Oncology
|
July 26, 2014
Local control after fractionated stereotactic radiation therapy for brain metastases
Selvan Rajakesari, Nils D Arvold, Rachel B Jimenez, et al.
Page
of 33